# LUMINARY THERAPEUTICS, INC.: Allogeneic BAFF Ligand Based CAR T Cells as a Novel Therapy for B Cell Malignancies

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | LUMINARY THERAPEUTICS, INC. |
| Location | MINNEAPOLIS, MN |
| Project | Allogeneic BAFF Ligand Based CAR T Cells as a Novel Therapy for B Cell Malignancies |
| Project number | 5R44CA278021-03 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $586,799 |
| Awarded | 2026-09-10 |
| Project period | 2023-07-01 to 2027-08-31 |
| UEI | MNKBAEZHWJS1 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11421504). Last refreshed: 2026-11-04T21:37:56.465Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.